InsiderSignal.AI

InsiderSignal.ai

LGND - Ligand Pharmaceuticals Inc

Insider Sale by Kozarich John W (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Kozarich John W, serving as Dir at Ligand Pharmaceuticals Inc (LGND), sold 467 shares at $200.50 per share, for a total transaction value of $93,632.00. Following this transaction, Kozarich John W now holds 42,720 shares of LGND.

This sale represents a 1.00% decrease in Kozarich John W's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Ligand Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Kozarich John W

Dir

John W. Kozarich, Ph.D. is an independent Director at Ligand Pharmaceuticals Incorporated (LGND) since March 2003, serving on the Nominating & Corporate Governance Committee with 100% attendance at board and committee meetings in 2024.[[1]](https://fintool.com/app/research/companies/LGND/people/john-kozarich)[[2]](https://www.ligand.com/aboutus/team/) Age 75, he brings extensive expertise in pharmaceutical R&D and leadership, highlighted by his role as Vice President at Merck Research Laboratories (1992–2001), Chairman and President of ActivX Biosciences (2004–2017), and key contributions at Alkermes during its pre-IPO phase.[[1]](https://fintool.com/app/research/companies/LGND/people/john-kozarich)[[2]](https://www.ligand.com/aboutus/team/)[[5]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3709828/) Dr. Kozarich is currently CEO and Co-Founder of Marsal Therapeutics (since November 2021) and Paludatus Pharmaceuticals, LLC (since June 2022), and serves as an Adjunct Professor of Chemical Biology and Medicinal Chemistry at the University of Texas at Austin (since September 2019).[[1]](https://fintool.com/app/research/companies/LGND/people/john-kozarich)[[2]](https://www.ligand.com/aboutus/team/)[[3]](https://www.paludatus.com/leadership/executive-team) His education includes a B.S. in Chemistry, summa cum laude, from Boston College, a Ph.D. in Biological Chemistry from MIT, and an NIH Postdoctoral Fellowship at Harvard; he received the Distinguished Scientist Award from the San Diego Section of the American Chemical Society.[[1]](https://fintool.com/app/research/companies/LGND/people/john-kozarich)[[2]](https://www.ligand.com/aboutus/team/) Previously, he held professorships at Yale University School of Medicine (1977–1984) and the University of Maryland (1984–1994), and served on boards including Curza Global (2019–2024).[[1]](https://fintool.com/app/research/companies/LGND/people/john-kozarich)[[2]](https://www.ligand.com/aboutus/team/)

View full insider profile →

Trade Price

$200.50

Quantity

467

Total Value

$93,632.00

Shares Owned

42,720

Trade Date

Monday, March 2, 2026

3 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Ligand Pharmaceuticals Inc

Company Overview

No company information available
View news mentioning LGND

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4502151

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime